- Home
- ASRT vs NVCT Comparison
ASRT vs NVCT Comparison
Compare ASRT & NVCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ASRT | NVCT |
|---|---|---|
| Founded | 1995 | 2020 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Medicinal Chemicals and Botanical Products |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 69.2M | 167.0M |
| IPO Year | 1997 | 2022 |
Fundamental Metrics
Financial Performance| Metric | ASRT | NVCT |
|---|---|---|
| Price | $0.74 | $6.22 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 3 |
| Target Price | $3.00 | ★ $15.33 |
| AVG Volume (30 Days) | ★ 728.9K | 89.1K |
| Earning Date | 11-10-2025 | 11-04-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $137,354,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $4.10 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 9.22 | N/A |
| 52 Week Low | $0.51 | $4.44 |
| 52 Week High | $1.08 | $11.52 |
Technical Indicators
Market Signals| Indicator | ASRT | NVCT |
|---|---|---|
| Relative Strength Index (RSI) | 43.31 | 54.35 |
| Support Level | $0.65 | $5.85 |
| Resistance Level | $0.79 | $6.21 |
| Average True Range (ATR) | 0.06 | 0.28 |
| MACD | -0.00 | 0.02 |
| Stochastic Oscillator | 29.25 | 70.91 |
Price Performance
Historical ComparisonAbout ASRT Assertio Holdings Inc.
Assertio Holdings Inc is a pharmaceutical company. It is engaged in providing solutions to advance patient care in the areas of neurology, orphan and specialty medicines. The company markets three FDA-approved products for various neurological conditions including Gralise, tablets for the management of postherpetic neuralgia; CAMBIA, for acute treatment of migraine attacks with or without aura in adults of age or older and Zipsor, liquid-filled capsules for relief of mild to moderate pain.
About NVCT Nuvectis Pharma Inc.
Nuvectis Pharma Inc is a biopharmaceutical company. The company is engaged in the development of innovative precision medicines for the treatment of serious conditions of unmet medical needs in oncology. It operates with one segment, focused on the development of novel targeted small molecule therapeutics for the treatment of cancer in genetically defined patient populations. Its pipeline products include NXP800, NXP900.